TIROSINT

Drug Akrimax Pharmaceuticals, LLC
Total Payments
$16,875
Transactions
6
Doctors
6
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2018 $2,700 1 1
2017 $14,175 5 5

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $16,875 6 100.0%

Top Doctors Receiving Payments for TIROSINT

Doctor Specialty Location Total Records
, DO Endocrinology, Diabetes & Metabolism Sterling Heights, MI $4,050 1
, M.D Endocrinology, Diabetes & Metabolism Westwood, NJ $2,700 1
, M.D Endocrinology, Diabetes & Metabolism Tampa, FL $2,700 1
, DO Endocrinology, Diabetes & Metabolism Hillsborough, NJ $2,700 1
, M.D Endocrinology, Diabetes & Metabolism Newport Beach, CA $2,475 1
, MD Endocrinology, Diabetes & Metabolism Raleigh, NC $2,250 1

About TIROSINT

TIROSINT is a drug associated with $16,875 in payments to 6 healthcare providers, recorded across 6 transactions in the CMS Open Payments database. The primary manufacturer is Akrimax Pharmaceuticals, LLC.

Payment data is available from 2017 to 2018. In 2018, $2,700 was paid across 1 transactions to 1 doctors.

The most common payment nature for TIROSINT is "Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program" ($16,875, 100.0% of total).